Although FOXO3a has been examined in its response to metformin numerous times in cancer-based cell lines43–46 and model organisms47, there appear to be no studies reporting the impact of metformin on FOXO3a in primary human cell-lines. The gene discussed is FOXO3; the disease is cancer.